The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biodegradable Drug Eluting Stents Market Research Report 2025
Synopsis
Biodegradable Polymer Drug-eluting Stents (BP-DES) are medical devices used in the treatment of coronary artery disease. Unlike traditional stents that use permanent polymer coatings to release drugs, BP-DES incorporate biodegradable polymers that gradually degrade over time, leaving behind only the bare metal stent. These stents are designed to release drugs, typically anti-proliferative or anti-inflammatory agents, to prevent restenosis (re-narrowing of the artery) after angioplasty. The biodegradable polymer technology reduces the risk of long-term complications associated with permanent polymer stents, such as inflammation and late stent thrombosis, while still providing effective drug delivery to inhibit cell growth and maintain vessel patency.
The global Biodegradable Drug Eluting Stents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Biodegradable Drug Eluting Stents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biodegradable Drug Eluting Stents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Biodegradable Drug Eluting Stents include Boston Scientific, Biotronik, Biosensors International, TERUMO, MicroPort Scientific, Lepu Medical, JW Medical, SINOMED, Bio-heart, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biodegradable Drug Eluting Stents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biodegradable Drug Eluting Stents.
The Biodegradable Drug Eluting Stents market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Biodegradable Drug Eluting Stents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biodegradable Drug Eluting Stents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Boston Scientific
Biotronik
Biosensors International
TERUMO
MicroPort Scientific
Lepu Medical
JW Medical
SINOMED
Bio-heart
Segment by Type
30 Days
60 Days
90 Days
Segment by Application
Direct Selling
Distribution
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biodegradable Drug Eluting Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biodegradable Drug Eluting Stents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Biodegradable Polymer Drug-eluting Stents (BP-DES) are medical devices used in the treatment of coronary artery disease. Unlike traditional stents that use permanent polymer coatings to release drugs, BP-DES incorporate biodegradable polymers that gradually degrade over time, leaving behind only the bare metal stent. These stents are designed to release drugs, typically anti-proliferative or anti-inflammatory agents, to prevent restenosis (re-narrowing of the artery) after angioplasty. The biodegradable polymer technology reduces the risk of long-term complications associated with permanent polymer stents, such as inflammation and late stent thrombosis, while still providing effective drug delivery to inhibit cell growth and maintain vessel patency.
The global Biodegradable Drug Eluting Stents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Biodegradable Drug Eluting Stents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biodegradable Drug Eluting Stents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Biodegradable Drug Eluting Stents include Boston Scientific, Biotronik, Biosensors International, TERUMO, MicroPort Scientific, Lepu Medical, JW Medical, SINOMED, Bio-heart, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biodegradable Drug Eluting Stents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biodegradable Drug Eluting Stents.
The Biodegradable Drug Eluting Stents market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Biodegradable Drug Eluting Stents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biodegradable Drug Eluting Stents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Boston Scientific
Biotronik
Biosensors International
TERUMO
MicroPort Scientific
Lepu Medical
JW Medical
SINOMED
Bio-heart
Segment by Type
30 Days
60 Days
90 Days
Segment by Application
Direct Selling
Distribution
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biodegradable Drug Eluting Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biodegradable Drug Eluting Stents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Biodegradable Drug Eluting Stents Market Overview
1.1 Product Definition
1.2 Biodegradable Drug Eluting Stents by Type
1.2.1 Global Biodegradable Drug Eluting Stents Market Value Comparison by Type (2024-2030)
1.2.2 30 Days
1.2.3 60 Days
1.2.4 90 Days
1.3 Biodegradable Drug Eluting Stents by Application
1.3.1 Global Biodegradable Drug Eluting Stents Market Value by Application (2024-2030)
1.3.2 Direct Selling
1.3.3 Distribution
1.4 Global Biodegradable Drug Eluting Stents Market Size Estimates and Forecasts
1.4.1 Global Biodegradable Drug Eluting Stents Revenue 2019-2030
1.4.2 Global Biodegradable Drug Eluting Stents Sales 2019-2030
1.4.3 Global Biodegradable Drug Eluting Stents Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Biodegradable Drug Eluting Stents Market Competition by Manufacturers
2.1 Global Biodegradable Drug Eluting Stents Sales Market Share by Manufacturers (2019-2024)
2.2 Global Biodegradable Drug Eluting Stents Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Biodegradable Drug Eluting Stents Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Biodegradable Drug Eluting Stents, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biodegradable Drug Eluting Stents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biodegradable Drug Eluting Stents, Product Type & Application
2.7 Global Key Manufacturers of Biodegradable Drug Eluting Stents, Date of Enter into This Industry
2.8 Global Biodegradable Drug Eluting Stents Market Competitive Situation and Trends
2.8.1 Global Biodegradable Drug Eluting Stents Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Biodegradable Drug Eluting Stents Players Market Share by Revenue
2.8.3 Global Biodegradable Drug Eluting Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Biodegradable Drug Eluting Stents Market Scenario by Region
3.1 Global Biodegradable Drug Eluting Stents Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Biodegradable Drug Eluting Stents Sales by Region: 2019-2030
3.2.1 Global Biodegradable Drug Eluting Stents Sales by Region: 2019-2024
3.2.2 Global Biodegradable Drug Eluting Stents Sales by Region: 2025-2030
3.3 Global Biodegradable Drug Eluting Stents Revenue by Region: 2019-2030
3.3.1 Global Biodegradable Drug Eluting Stents Revenue by Region: 2019-2024
3.3.2 Global Biodegradable Drug Eluting Stents Revenue by Region: 2025-2030
3.4 North America Biodegradable Drug Eluting Stents Market Facts & Figures by Country
3.4.1 North America Biodegradable Drug Eluting Stents Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Biodegradable Drug Eluting Stents Sales by Country (2019-2030)
3.4.3 North America Biodegradable Drug Eluting Stents Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biodegradable Drug Eluting Stents Market Facts & Figures by Country
3.5.1 Europe Biodegradable Drug Eluting Stents Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Biodegradable Drug Eluting Stents Sales by Country (2019-2030)
3.5.3 Europe Biodegradable Drug Eluting Stents Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biodegradable Drug Eluting Stents Market Facts & Figures by Region
3.6.1 Asia Pacific Biodegradable Drug Eluting Stents Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Biodegradable Drug Eluting Stents Sales by Region (2019-2030)
3.6.3 Asia Pacific Biodegradable Drug Eluting Stents Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Biodegradable Drug Eluting Stents Market Facts & Figures by Country
3.7.1 Latin America Biodegradable Drug Eluting Stents Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Biodegradable Drug Eluting Stents Sales by Country (2019-2030)
3.7.3 Latin America Biodegradable Drug Eluting Stents Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Biodegradable Drug Eluting Stents Market Facts & Figures by Country
3.8.1 Middle East and Africa Biodegradable Drug Eluting Stents Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Biodegradable Drug Eluting Stents Sales by Country (2019-2030)
3.8.3 Middle East and Africa Biodegradable Drug Eluting Stents Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biodegradable Drug Eluting Stents Sales by Type (2019-2030)
4.1.1 Global Biodegradable Drug Eluting Stents Sales by Type (2019-2024)
4.1.2 Global Biodegradable Drug Eluting Stents Sales by Type (2025-2030)
4.1.3 Global Biodegradable Drug Eluting Stents Sales Market Share by Type (2019-2030)
4.2 Global Biodegradable Drug Eluting Stents Revenue by Type (2019-2030)
4.2.1 Global Biodegradable Drug Eluting Stents Revenue by Type (2019-2024)
4.2.2 Global Biodegradable Drug Eluting Stents Revenue by Type (2025-2030)
4.2.3 Global Biodegradable Drug Eluting Stents Revenue Market Share by Type (2019-2030)
4.3 Global Biodegradable Drug Eluting Stents Price by Type (2019-2030)
5 Segment by Application
5.1 Global Biodegradable Drug Eluting Stents Sales by Application (2019-2030)
5.1.1 Global Biodegradable Drug Eluting Stents Sales by Application (2019-2024)
5.1.2 Global Biodegradable Drug Eluting Stents Sales by Application (2025-2030)
5.1.3 Global Biodegradable Drug Eluting Stents Sales Market Share by Application (2019-2030)
5.2 Global Biodegradable Drug Eluting Stents Revenue by Application (2019-2030)
5.2.1 Global Biodegradable Drug Eluting Stents Revenue by Application (2019-2024)
5.2.2 Global Biodegradable Drug Eluting Stents Revenue by Application (2025-2030)
5.2.3 Global Biodegradable Drug Eluting Stents Revenue Market Share by Application (2019-2030)
5.3 Global Biodegradable Drug Eluting Stents Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Company Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Biodegradable Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boston Scientific Biodegradable Drug Eluting Stents Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Biotronik
6.2.1 Biotronik Company Information
6.2.2 Biotronik Description and Business Overview
6.2.3 Biotronik Biodegradable Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Biotronik Biodegradable Drug Eluting Stents Product Portfolio
6.2.5 Biotronik Recent Developments/Updates
6.3 Biosensors International
6.3.1 Biosensors International Company Information
6.3.2 Biosensors International Description and Business Overview
6.3.3 Biosensors International Biodegradable Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Biosensors International Biodegradable Drug Eluting Stents Product Portfolio
6.3.5 Biosensors International Recent Developments/Updates
6.4 TERUMO
6.4.1 TERUMO Company Information
6.4.2 TERUMO Description and Business Overview
6.4.3 TERUMO Biodegradable Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 TERUMO Biodegradable Drug Eluting Stents Product Portfolio
6.4.5 TERUMO Recent Developments/Updates
6.5 MicroPort Scientific
6.5.1 MicroPort Scientific Company Information
6.5.2 MicroPort Scientific Description and Business Overview
6.5.3 MicroPort Scientific Biodegradable Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.5.4 MicroPort Scientific Biodegradable Drug Eluting Stents Product Portfolio
6.5.5 MicroPort Scientific Recent Developments/Updates
6.6 Lepu Medical
6.6.1 Lepu Medical Company Information
6.6.2 Lepu Medical Description and Business Overview
6.6.3 Lepu Medical Biodegradable Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lepu Medical Biodegradable Drug Eluting Stents Product Portfolio
6.6.5 Lepu Medical Recent Developments/Updates
6.7 JW Medical
6.7.1 JW Medical Company Information
6.7.2 JW Medical Description and Business Overview
6.7.3 JW Medical Biodegradable Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.7.4 JW Medical Biodegradable Drug Eluting Stents Product Portfolio
6.7.5 JW Medical Recent Developments/Updates
6.8 SINOMED
6.8.1 SINOMED Company Information
6.8.2 SINOMED Description and Business Overview
6.8.3 SINOMED Biodegradable Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.8.4 SINOMED Biodegradable Drug Eluting Stents Product Portfolio
6.8.5 SINOMED Recent Developments/Updates
6.9 Bio-heart
6.9.1 Bio-heart Company Information
6.9.2 Bio-heart Description and Business Overview
6.9.3 Bio-heart Biodegradable Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bio-heart Biodegradable Drug Eluting Stents Product Portfolio
6.9.5 Bio-heart Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biodegradable Drug Eluting Stents Industry Chain Analysis
7.2 Biodegradable Drug Eluting Stents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biodegradable Drug Eluting Stents Production Mode & Process
7.4 Biodegradable Drug Eluting Stents Sales and Marketing
7.4.1 Biodegradable Drug Eluting Stents Sales Channels
7.4.2 Biodegradable Drug Eluting Stents Distributors
7.5 Biodegradable Drug Eluting Stents Customers
8 Biodegradable Drug Eluting Stents Market Dynamics
8.1 Biodegradable Drug Eluting Stents Industry Trends
8.2 Biodegradable Drug Eluting Stents Market Drivers
8.3 Biodegradable Drug Eluting Stents Market Challenges
8.4 Biodegradable Drug Eluting Stents Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Biodegradable Drug Eluting Stents Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Biodegradable Drug Eluting Stents Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Biodegradable Drug Eluting Stents Market Competitive Situation by Manufacturers in 2023
Table 4. Global Biodegradable Drug Eluting Stents Sales (Units) of Key Manufacturers (2019-2024)
Table 5. Global Biodegradable Drug Eluting Stents Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Biodegradable Drug Eluting Stents Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Biodegradable Drug Eluting Stents Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Biodegradable Drug Eluting Stents Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Biodegradable Drug Eluting Stents, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Biodegradable Drug Eluting Stents, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Biodegradable Drug Eluting Stents, Product Type & Application
Table 12. Global Key Manufacturers of Biodegradable Drug Eluting Stents, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biodegradable Drug Eluting Stents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biodegradable Drug Eluting Stents as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Biodegradable Drug Eluting Stents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Biodegradable Drug Eluting Stents Sales by Region (2019-2024) & (Units)
Table 18. Global Biodegradable Drug Eluting Stents Sales Market Share by Region (2019-2024)
Table 19. Global Biodegradable Drug Eluting Stents Sales by Region (2025-2030) & (Units)
Table 20. Global Biodegradable Drug Eluting Stents Sales Market Share by Region (2025-2030)
Table 21. Global Biodegradable Drug Eluting Stents Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Biodegradable Drug Eluting Stents Revenue Market Share by Region (2019-2024)
Table 23. Global Biodegradable Drug Eluting Stents Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Biodegradable Drug Eluting Stents Revenue Market Share by Region (2025-2030)
Table 25. North America Biodegradable Drug Eluting Stents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Biodegradable Drug Eluting Stents Sales by Country (2019-2024) & (Units)
Table 27. North America Biodegradable Drug Eluting Stents Sales by Country (2025-2030) & (Units)
Table 28. North America Biodegradable Drug Eluting Stents Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Biodegradable Drug Eluting Stents Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Biodegradable Drug Eluting Stents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Biodegradable Drug Eluting Stents Sales by Country (2019-2024) & (Units)
Table 32. Europe Biodegradable Drug Eluting Stents Sales by Country (2025-2030) & (Units)
Table 33. Europe Biodegradable Drug Eluting Stents Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Biodegradable Drug Eluting Stents Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Biodegradable Drug Eluting Stents Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Biodegradable Drug Eluting Stents Sales by Region (2019-2024) & (Units)
Table 37. Asia Pacific Biodegradable Drug Eluting Stents Sales by Region (2025-2030) & (Units)
Table 38. Asia Pacific Biodegradable Drug Eluting Stents Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Biodegradable Drug Eluting Stents Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Biodegradable Drug Eluting Stents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Biodegradable Drug Eluting Stents Sales by Country (2019-2024) & (Units)
Table 42. Latin America Biodegradable Drug Eluting Stents Sales by Country (2025-2030) & (Units)
Table 43. Latin America Biodegradable Drug Eluting Stents Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Biodegradable Drug Eluting Stents Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Biodegradable Drug Eluting Stents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Biodegradable Drug Eluting Stents Sales by Country (2019-2024) & (Units)
Table 47. Middle East and Africa Biodegradable Drug Eluting Stents Sales by Country (2025-2030) & (Units)
Table 48. Middle East and Africa Biodegradable Drug Eluting Stents Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Biodegradable Drug Eluting Stents Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Biodegradable Drug Eluting Stents Sales (Units) by Type (2019-2024)
Table 51. Global Biodegradable Drug Eluting Stents Sales (Units) by Type (2025-2030)
Table 52. Global Biodegradable Drug Eluting Stents Sales Market Share by Type (2019-2024)
Table 53. Global Biodegradable Drug Eluting Stents Sales Market Share by Type (2025-2030)
Table 54. Global Biodegradable Drug Eluting Stents Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Biodegradable Drug Eluting Stents Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Biodegradable Drug Eluting Stents Revenue Market Share by Type (2019-2024)
Table 57. Global Biodegradable Drug Eluting Stents Revenue Market Share by Type (2025-2030)
Table 58. Global Biodegradable Drug Eluting Stents Price (US$/Unit) by Type (2019-2024)
Table 59. Global Biodegradable Drug Eluting Stents Price (US$/Unit) by Type (2025-2030)
Table 60. Global Biodegradable Drug Eluting Stents Sales (Units) by Application (2019-2024)
Table 61. Global Biodegradable Drug Eluting Stents Sales (Units) by Application (2025-2030)
Table 62. Global Biodegradable Drug Eluting Stents Sales Market Share by Application (2019-2024)
Table 63. Global Biodegradable Drug Eluting Stents Sales Market Share by Application (2025-2030)
Table 64. Global Biodegradable Drug Eluting Stents Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Biodegradable Drug Eluting Stents Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Biodegradable Drug Eluting Stents Revenue Market Share by Application (2019-2024)
Table 67. Global Biodegradable Drug Eluting Stents Revenue Market Share by Application (2025-2030)
Table 68. Global Biodegradable Drug Eluting Stents Price (US$/Unit) by Application (2019-2024)
Table 69. Global Biodegradable Drug Eluting Stents Price (US$/Unit) by Application (2025-2030)
Table 70. Boston Scientific Company Information
Table 71. Boston Scientific Description and Business Overview
Table 72. Boston Scientific Biodegradable Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Boston Scientific Biodegradable Drug Eluting Stents Product
Table 74. Boston Scientific Recent Developments/Updates
Table 75. Biotronik Company Information
Table 76. Biotronik Description and Business Overview
Table 77. Biotronik Biodegradable Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Biotronik Biodegradable Drug Eluting Stents Product
Table 79. Biotronik Recent Developments/Updates
Table 80. Biosensors International Company Information
Table 81. Biosensors International Description and Business Overview
Table 82. Biosensors International Biodegradable Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Biosensors International Biodegradable Drug Eluting Stents Product
Table 84. Biosensors International Recent Developments/Updates
Table 85. TERUMO Company Information
Table 86. TERUMO Description and Business Overview
Table 87. TERUMO Biodegradable Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. TERUMO Biodegradable Drug Eluting Stents Product
Table 89. TERUMO Recent Developments/Updates
Table 90. MicroPort Scientific Company Information
Table 91. MicroPort Scientific Description and Business Overview
Table 92. MicroPort Scientific Biodegradable Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. MicroPort Scientific Biodegradable Drug Eluting Stents Product
Table 94. MicroPort Scientific Recent Developments/Updates
Table 95. Lepu Medical Company Information
Table 96. Lepu Medical Description and Business Overview
Table 97. Lepu Medical Biodegradable Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Lepu Medical Biodegradable Drug Eluting Stents Product
Table 99. Lepu Medical Recent Developments/Updates
Table 100. JW Medical Company Information
Table 101. JW Medical Description and Business Overview
Table 102. JW Medical Biodegradable Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. JW Medical Biodegradable Drug Eluting Stents Product
Table 104. JW Medical Recent Developments/Updates
Table 105. SINOMED Company Information
Table 106. SINOMED Description and Business Overview
Table 107. SINOMED Biodegradable Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. SINOMED Biodegradable Drug Eluting Stents Product
Table 109. SINOMED Recent Developments/Updates
Table 110. Bio-heart Company Information
Table 111. Bio-heart Description and Business Overview
Table 112. Bio-heart Biodegradable Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Bio-heart Biodegradable Drug Eluting Stents Product
Table 114. Bio-heart Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Biodegradable Drug Eluting Stents Distributors List
Table 118. Biodegradable Drug Eluting Stents Customers List
Table 119. Biodegradable Drug Eluting Stents Market Trends
Table 120. Biodegradable Drug Eluting Stents Market Drivers
Table 121. Biodegradable Drug Eluting Stents Market Challenges
Table 122. Biodegradable Drug Eluting Stents Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Biodegradable Drug Eluting Stents
Figure 2. Global Biodegradable Drug Eluting Stents Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Biodegradable Drug Eluting Stents Market Share by Type: 2023 & 2030
Figure 4. 30 Days Product Picture
Figure 5. 60 Days Product Picture
Figure 6. 90 Days Product Picture
Figure 7. Global Biodegradable Drug Eluting Stents Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Biodegradable Drug Eluting Stents Market Share by Application: 2023 & 2030
Figure 9. Direct Selling
Figure 10. Distribution
Figure 11. Global Biodegradable Drug Eluting Stents Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Biodegradable Drug Eluting Stents Market Size (2019-2030) & (US$ Million)
Figure 13. Global Biodegradable Drug Eluting Stents Sales (2019-2030) & (Units)
Figure 14. Global Biodegradable Drug Eluting Stents Average Price (US$/Unit) & (2019-2030)
Figure 15. Biodegradable Drug Eluting Stents Report Years Considered
Figure 16. Biodegradable Drug Eluting Stents Sales Share by Manufacturers in 2023
Figure 17. Global Biodegradable Drug Eluting Stents Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Biodegradable Drug Eluting Stents Players: Market Share by Revenue in Biodegradable Drug Eluting Stents in 2023
Figure 19. Biodegradable Drug Eluting Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Biodegradable Drug Eluting Stents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Biodegradable Drug Eluting Stents Sales Market Share by Country (2019-2030)
Figure 22. North America Biodegradable Drug Eluting Stents Revenue Market Share by Country (2019-2030)
Figure 23. United States Biodegradable Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Biodegradable Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Biodegradable Drug Eluting Stents Sales Market Share by Country (2019-2030)
Figure 26. Europe Biodegradable Drug Eluting Stents Revenue Market Share by Country (2019-2030)
Figure 27. Germany Biodegradable Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Biodegradable Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Biodegradable Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Biodegradable Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Biodegradable Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Biodegradable Drug Eluting Stents Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Biodegradable Drug Eluting Stents Revenue Market Share by Region (2019-2030)
Figure 34. China Biodegradable Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Biodegradable Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Biodegradable Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Biodegradable Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Biodegradable Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Biodegradable Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Biodegradable Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Biodegradable Drug Eluting Stents Sales Market Share by Country (2019-2030)
Figure 42. Mexico Biodegradable Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Biodegradable Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Biodegradable Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Biodegradable Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Biodegradable Drug Eluting Stents Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Biodegradable Drug Eluting Stents Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Biodegradable Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Biodegradable Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Biodegradable Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Biodegradable Drug Eluting Stents by Type (2019-2030)
Figure 52. Global Revenue Market Share of Biodegradable Drug Eluting Stents by Type (2019-2030)
Figure 53. Global Biodegradable Drug Eluting Stents Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Biodegradable Drug Eluting Stents by Application (2019-2030)
Figure 55. Global Revenue Market Share of Biodegradable Drug Eluting Stents by Application (2019-2030)
Figure 56. Global Biodegradable Drug Eluting Stents Price (US$/Unit) by Application (2019-2030)
Figure 57. Biodegradable Drug Eluting Stents Value Chain
Figure 58. Biodegradable Drug Eluting Stents Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
